
Sign up to save your podcasts
Or


Neuromodulation is a rapidly growing market, with significant investments in pelvic health, including Boston Scientific's $3.4 billion acquisition of Axonics and funding for Amber Therapeutics, Neuspera Medical, and Avation Medical. David Constantine, Co-Founder and CEO of Juniper Biomedical, has leveraged his career experiences to drive their mission of revolutionizing pelvic health through precision neuromodulation. His passion for impactful work highlights the importance of finding meaningful career paths that motivate and sustain us through challenges. This conversation with David underscored the timely relevance of their innovative approach in transforming patient outcomes.
As cancer treatments become better at fighting the disease itself, there is much to do regarding side effects like oral mucositis. This condition is common, up to 80% of those receiving high dose chemotherapy can suffer from this painful and potentially deadly side effect. There is hope with technology stemming from MuReva Phototherapy.
In this chat with Vedang Kothari, the founder of MuReva, he explained the effectiveness of photomodulation for this condition, and the treatment modality the team has created.
I sat down with David Kuraguntla, CEO of Alio, to discuss their groundbreaking multi-metric wearable, the first to monitor potassium levels, a key health indicator. With FDA clearance and impressive data, Alio aims to revolutionize healthcare with valuable, actionable information. David shared insights into the development journey and challenges faced. Tune in to explore the future of healthcare technology and innovation.
In this episode of Tech Talks, I had a great conversation with Ananth Ravi, President and CEO of MOLLI Surgical, about their patient-focused approach to technology. Ananth shared how they aim to improve the patient experience and clinical processes.
I had an exciting and informative discussion with Conor Walsh, Co-Founder of Imago Rehab and founder of Harvard Biodesign Lab. Conor, who holds a PhD from Massachusetts Institute of Technology and is a professor in Engineering and Applied Science at Harvard University, discussed his research on developing innovative robotic technologies to improve human performance. He explained how the Imago technology was conceived and his work with soft flexible robotic systems that could revolutionize health and rehabilitation.
Frank Bonnet, the founder and CEO of Bionomous - a robotics startup - shares his insights on Tech Talks. They are currently working on an innovative project that automates the sorting and categorization of zebrafish, a widely-used process in clinical research due to its similar genetic structure to humans. The conversation is engaging, and Frank and his team are definitely a company worth watching.
Rob Eno, President of HeartBeam Inc., discussed the rapid evolution of technology and clinical care in a recent chat. He highlighted the excitement of this platform technology and will discuss further in the #TechTalks Podcast next week.
The medical device industry is supposed to be hard. We have patients relying on the trust of our clinicians, governing bodies, and manufacturers to put them first. This conversation with Mark A. Turco, M.D., F.A.C.C. , CEO of JC Medical, Inc. and President, Genesis Intervention, highlights so much of why we are focused in innovation in this industry.
In a recent chat with Marissa Fayer, CEO of DeepLook Medical and non-profit HERhealthEQ, Marissa shared how the importance of awareness and attention on the issues with women in focus, and how her companies are pioneering new trails for better healthcare.
A successful startup requires customized support. That is exactly what Paul Grand, CEO MedTech Innovator, shared in our chat on TechTalks. The power of MedTech Innovator lies in the resources.
From the publisher's feed
TechTalks with Holly Scott is a podcast showcasing new innovation in the MedTech industry, and the trials and tribulations associated with moving new technologies to the marketplace.